Want to join the conversation?
$ABBV said that its adjusted R&D expense was 15.9% of net revenues in 4Q15, reflecting funding actions in support of its mid- and late-stage pipeline. The company's adjusted operating margin in during quarter was 40.1%, compared to 35.8% in 4Q14. On a GAAP basis, the operating margin was 33%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?